Total Valuation
BJ Bio-Tech Development Management Group Holding has a market cap or net worth of $61.67M. The enterprise value is ―.
Market Cap$61.67M
Enterprise Value―
Share Statistics
BJ Bio-Tech Development Management Group Holding has 1,010,944,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,010,944,150
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BJ Bio-Tech Development Management Group Holding’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count40
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of BJ Bio-Tech Development Management Group Holding is ―. BJ Bio-Tech Development Management Group Holding’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, BJ Bio-Tech Development Management Group Holding had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
BJ Bio-Tech Development Management Group Holding pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta264.09
52-Week Price Change-87.92%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)0.00
Important Dates
BJ Bio-Tech Development Management Group Holding upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
BJ Bio-Tech Development Management Group Holding as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, BJ Bio-Tech Development Management Group Holding has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
BJ Bio-Tech Development Management Group Holding EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
BJ Bio-Tech Development Management Group Holding has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for BJ Bio-Tech Development Management Group Holding is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―